Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 9/20 | 0.54 |
| ▸ | IKZF2 | Q9UKS7 | 8/20 | 0.49 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.48 |
| ▸ | WIZ | O95785 | 2/20 | 0.48 |
| ▸ | GSPT1 | P15170 | 1/20 | 0.45 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.45 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.45 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27301548 | 0.84 | CRBN (0.56) | CRBNIKZF2CSNK1A1WIZDDB1 | |
| SCHEMBL20046704 | 0.84 | CRBN (0.56) | CRBNIKZF2CSNK1A1WIZDDB1 | |
| SCHEMBL31611548 | 0.84 | CRBN (0.56) | CRBNIKZF2CSNK1A1WIZDDB1 | |
| SCHEMBL30720192 | 0.84 | CRBN (0.56) | CRBNIKZF2CSNK1A1WIZDDB1 | |
| SCHEMBL30720169 | 0.84 | CRBN (0.56) | CRBNIKZF2CSNK1A1WIZDDB1 | |
| SCHEMBL29547522 | 0.84 | CRBN (0.56) | CRBNIKZF2CSNK1A1WIZDDB1 | |
| SCHEMBL20231651 | 0.84 | CRBN (0.53) | CRBNIKZF2CSNK1A1WIZDDB1 | |
| SCHEMBL25929611 | 0.82 | CRBN (0.49) | CRBNIKZF2CSNK1A1WIZDDB1 | |
| SCHEMBL30930637 | 0.82 | CRBN (0.55) | CRBNIKZF2WIZDDB1IKZF1 | |
| SCHEMBL29767388 | 0.82 | CRBN (0.55) | CRBNIKZF2WIZDDB1IKZF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612140-A1 | NEK7 DEGRADERS AND METHODS OF USE THEREOF | Captor Therapeutics S.A. (PL) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024094819-A1 | NEK7 DEGRADERS AND METHODS OF USE THEREOF | CAPTOR THERAPEUTICS S.A. (PL) | 2024-05-10 | — | — | WO | disclosed |